UX023-CL401-X-linked Hypophosphatemia Disease Monitoring Program - XLH-DMP

Project: Research project

Project Details

StatusActive
Effective start/end date4/30/188/31/50

Funding

  • Ultragenyx Pharmaceutical Inc.